MAPT and Alzheimer disease: In recent years, many studies have shown that D-galactose-induced aging models also have AD-like pathology (30, 31), including oxidative stress damage (32), neuroinflammation (33), dysregulation of APP metabolism (34), and phosphorylation of Aβ and Tau proteins(35).